| First Author | Clouston WM | Year | 1989 |
| Journal | EMBO J | Volume | 8 |
| Issue | 11 | Pages | 3337-43 |
| PubMed ID | 2573515 | Mgi Jnum | J:20306 |
| Mgi Id | MGI:68406 | Doi | 10.1002/j.1460-2075.1989.tb08495.x |
| Citation | Clouston WM, et al. (1989) Tissue-specific and hormonal regulation of angiotensinogen minigenes in transgenic mice. EMBO J 8(11):3337-43 |
| abstractText | Angiotensinogen is the precursor of the potent vasoactive peptide angiotensin II, and is therefore an important determinant of blood pressure and electrolyte homeostasis. In order to map the tissue-specific and inducible enhancer elements governing angiotensinogen gene expression in transgenic mice, we constructed minigenes containing either 0.75 kb or 4 kb or 5' flanking DNA from the BALB/c angiotensinogen gene. Sequences necessary and sufficient to mediate induction by glucocorticoids, oestrogen and bacterial endotoxin were contained on the minigene bearing 0.75 kb of DNA upstream of the capsite. This construct was also able to confer tissue specificity in the majority of organs producing angiotensinogen. In the testis and salivary gland, differences between the donor (BALB/c) and recipient (Swiss) strains were responsible for the apparently aberrant expression of the minigene constructs. The genetic lesion responsible for these expression polymorphisms has been characterized using recombinant inbred mice. An EcoRI restriction fragment length polymorphism which co-segregates with the angiotensinogen expression phenotypes into many inbred mouse strains is also described. |
